Cell MedX Corp. Quarterly Accrued Liabilities, Current in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Cell MedX Corp. quarterly Accrued Liabilities, Current history and growth rate from Q4 2014 to Q3 2024.
  • Cell MedX Corp. Accrued Liabilities, Current for the quarter ending August 31, 2024 was $6.71K, a 84.2% decline year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.71K -$35.8K -84.2% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $28.1K -$8.5K -23.3% May 31, 2024 10-Q 2024-10-15
Q1 2024 $13.1K -$10.5K -44.5% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $8.33K -$23K -73.4% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 $42.5K +$10.7K +33.6% Aug 31, 2023 10-Q 2023-10-16
Q2 2023 $36.6K +$7.68K +26.6% May 31, 2023 10-K 2024-08-29
Q1 2023 $23.6K +$19.3K +443% Feb 28, 2023 10-Q 2023-06-29
Q4 2022 $31.3K +$27K +620% Nov 30, 2022 10-Q 2023-05-19
Q3 2022 $31.8K +$1.24K +4.05% Aug 31, 2022 10-Q 2023-04-19
Q2 2022 $28.9K -$6.31K -17.9% May 31, 2022 10-K 2023-09-01
Q1 2022 $4.35K -$530 -10.9% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $4.35K -$6K -58% Nov 30, 2021 10-Q 2022-01-12
Q3 2021 $30.6K +$211 +0.7% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $35.2K +$618 +1.79% May 31, 2021 10-K 2023-04-07
Q1 2021 $4.88K -$500 -9.29% Feb 28, 2021 10-Q 2021-04-09
Q4 2020 $10.4K -$18K -63.5% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $30.4K -$2.69K -8.13% Aug 31, 2020 10-Q 2020-10-15
Q2 2020 $34.6K +$8.93K +34.8% May 31, 2020 10-K 2021-08-30
Q1 2020 $5.38K -$2.12K -28.3% Feb 29, 2020 10-Q 2020-04-14
Q4 2019 $28.4K +$20.9K +279% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 $33K +$9.54K +40.6% Aug 31, 2019 10-Q 2019-10-15
Q2 2019 $25.6K +$5.04K +24.4% May 31, 2019 10-K 2020-09-15
Q1 2019 $7.5K +$1.5K +25% Feb 28, 2019 10-Q 2019-04-22
Q4 2018 $7.49K +$2.01K +36.7% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 $23.5K -$6.2K -20.9% Aug 31, 2018 10-Q/A 2018-10-16
Q2 2018 $20.6K -$59.6K -74.3% May 31, 2018 10-K 2019-09-06
Q1 2018 $6K -$3.33K -35.7% Feb 28, 2018 10-Q 2018-04-16
Q4 2017 $5.48K -$2.93K -34.8% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 $29.7K -$3.51K -10.6% Aug 31, 2017 10-Q 2017-10-17
Q2 2017 $80.2K +$42.2K +111% May 31, 2017 10-K 2018-09-13
Q1 2017 $9.33K -$1.22K -11.5% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 $8.41K -$270 -3.11% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 $33.2K +$1.59K +5.04% Aug 31, 2016 10-Q 2016-10-17
Q2 2016 $38K +$7.63K +25.1% May 31, 2016 10-K 2017-08-29
Q1 2016 $10.5K -$12.5K -54.2% Feb 29, 2016 10-Q 2016-04-14
Q4 2015 $8.68K -$10.8K -55.3% Nov 30, 2015 10-Q 2016-01-14
Q3 2015 $31.6K Aug 31, 2015 10-Q 2015-10-15
Q2 2015 $30.3K May 31, 2015 10-K 2016-09-13
Q1 2015 $23.1K Feb 28, 2015 10-Q 2015-04-14
Q4 2014 $19.4K Nov 30, 2014 10-Q 2015-01-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.